Advisor Resource Council’s Aurinia Pharmaceuticals AUPH Stock Holding History

Advisor Resource Council’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$177K	Buy	+11,425	New	+$183K	0.05%	262

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisor Resource Council's AUPH Position: Q2 2026 in Review

Advisor Resource Council opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 11,425 shares worth $177K. The stake represents 0.05% of the portfolio and ranks #262 among its holdings.

281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Advisor Resource Council held 11,425 shares of Aurinia Pharmaceuticals worth $177K as of Q2 2026.
Aurinia Pharmaceuticals was a new Advisor Resource Council position in Q2 2026.
Aurinia Pharmaceuticals made up 0.05% of Advisor Resource Council's portfolio in Q2 2026, its #262 holding.
281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Advisor Resource Council's 13F filing for Q2 2026, filed 28 Jul 2026.